Mollie Leoni, Chief Medical Officer at Kura Oncology, Inc. (KURA), sold 16,360 shares at $8.46 ($138K) on 2026-01-27, disclosed to the SEC on 2026-01-27.
Open-market sale of $138k KURA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.46 | 951 | $8K | 5.8% |
| 2 | $8.46 | 1,341 | $11K | 8.2% |
| 3 | $8.46 | 2,233 | $19K | 13.6% |
| 4 | $8.46 | 3,655 | $31K | 22.3% |
| 5 | $8.46 | 3,655 | $31K | 22.3% |
| 6 | $8.46 | 951 |
| $8K |
| 5.8% |
| 7 | $8.46 | 2,233 | $19K | 13.6% |
| 8 | $8.46 | 1,341 | $11K | 8.2% |
| Total | $8.46 avg | 16,360 | $138K | 100% |
| Filing → |
| KURA | SELL | 2025-11-14 | $346K | — | Filing → |
| KURA | SELL | 2025-09-29 | $220K | — | Filing → |
| KURA | SELL | 2025-01-28 | $39K | — | Filing → |